Further exploration of the mechanism by which SCFAs mediate Ace2 and Sh2b3 expression may lead to novel avenues for treatment not only of SARS-CoV-2 but a variety of disease states ranging from viral pneumonias to hypertension to stroke. Here, SH2B3 is linked to Hypertension.